Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Ahmed Sallam

Concepts (375)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vitrectomy
30
2024
58
9.780
Why?
Cataract
14
2024
45
7.590
Why?
Visual Acuity
36
2024
138
7.560
Why?
Macular Edema
16
2024
27
6.900
Why?
Phacoemulsification
15
2024
31
6.340
Why?
Cataract Extraction
14
2024
32
5.620
Why?
Retinal Detachment
14
2024
24
4.940
Why?
Diabetic Retinopathy
10
2024
40
4.860
Why?
Intraoperative Complications
15
2024
112
4.790
Why?
Tomography, Optical Coherence
19
2024
102
4.280
Why?
Uveitis
12
2024
29
4.110
Why?
Ophthalmology
8
2023
31
3.910
Why?
Glaucoma
8
2024
34
3.680
Why?
Endophthalmitis
11
2023
25
3.390
Why?
Epiretinal Membrane
5
2024
10
3.380
Why?
Glucocorticoids
15
2023
226
3.270
Why?
Eye Infections, Bacterial
8
2024
31
2.930
Why?
Dexamethasone
9
2023
430
2.790
Why?
Postoperative Complications
15
2024
996
2.770
Why?
Retrospective Studies
51
2024
6134
2.680
Why?
Drug Implants
9
2023
35
2.550
Why?
Triticum
4
2023
7
2.520
Why?
Humans
123
2024
50208
2.360
Why?
Fluorescein Angiography
7
2024
32
2.310
Why?
Syphilis
5
2024
27
2.300
Why?
Comprehension
5
2024
110
2.290
Why?
Lens Implantation, Intraocular
8
2024
22
2.170
Why?
Hordeum
3
2022
5
2.170
Why?
Vitreoretinal Surgery
5
2024
8
2.160
Why?
Intraocular Pressure
10
2024
55
2.080
Why?
Diabetes Mellitus
4
2022
286
2.030
Why?
Eye Infections, Fungal
6
2021
19
1.970
Why?
Retinal Vessels
3
2024
14
1.970
Why?
Retinal Vein Occlusion
6
2023
14
1.950
Why?
Papilledema
4
2022
27
1.930
Why?
Retinitis Pigmentosa
2
2024
7
1.850
Why?
Fluorocarbons
3
2023
45
1.540
Why?
Angiogenesis Inhibitors
7
2022
188
1.490
Why?
Fibrin
2
2023
10
1.470
Why?
Retinal Diseases
7
2021
50
1.460
Why?
Paracentesis
2
2023
13
1.450
Why?
Intravitreal Injections
15
2023
35
1.450
Why?
Aged
38
2024
9405
1.420
Why?
Middle Aged
41
2024
12206
1.410
Why?
Databases, Factual
10
2024
657
1.410
Why?
Sclera
2
2024
5
1.400
Why?
Male
58
2024
25399
1.380
Why?
Tissue Plasminogen Activator
2
2023
109
1.360
Why?
Aged, 80 and over
23
2024
3154
1.340
Why?
Lenses, Intraocular
2
2022
7
1.300
Why?
Macular Degeneration
4
2024
47
1.290
Why?
Retinal Perforations
4
2023
8
1.240
Why?
Female
55
2024
26635
1.210
Why?
Choroid
5
2024
24
1.200
Why?
Fractals
2
2024
8
1.190
Why?
Retina
7
2024
65
1.190
Why?
Iris Diseases
3
2020
4
1.160
Why?
Wet Macular Degeneration
3
2022
12
1.140
Why?
Candidiasis
3
2021
114
1.110
Why?
Eye Injuries
4
2024
27
1.070
Why?
Societies, Medical
3
2019
177
1.070
Why?
Adult
29
2024
13324
0.990
Why?
Retinitis
2
2022
5
0.970
Why?
Internet
2
2024
258
0.970
Why?
Endotamponade
4
2018
8
0.960
Why?
Lighting
1
2024
5
0.940
Why?
Ciliary Body
1
2024
4
0.930
Why?
Anterior Chamber
1
2023
8
0.920
Why?
Lens, Crystalline
1
2024
20
0.910
Why?
Laser Coagulation
1
2024
26
0.910
Why?
Ocular Hypertension
2
2016
6
0.910
Why?
Triamcinolone Acetonide
5
2011
15
0.900
Why?
Panuveitis
2
2021
6
0.900
Why?
Anesthesia, General
3
2024
91
0.900
Why?
Germination
1
2023
5
0.870
Why?
Endoscopy
1
2024
124
0.860
Why?
Occlusive Dressings
1
2022
6
0.850
Why?
Artificial Intelligence
1
2023
82
0.840
Why?
State Medicine
5
2023
14
0.840
Why?
HIV Seropositivity
1
2022
27
0.830
Why?
Rift Valley Fever
1
2022
1
0.830
Why?
Antihypertensive Agents
2
2016
121
0.820
Why?
Optic Neuropathy, Ischemic
1
2022
8
0.820
Why?
Eye Foreign Bodies
1
2022
7
0.810
Why?
Enbucrilate
1
2021
6
0.810
Why?
Tissue Adhesives
1
2021
13
0.800
Why?
Reproducibility of Results
7
2024
1185
0.780
Why?
Stress, Physiological
2
2019
170
0.770
Why?
Varicose Veins
2
2019
19
0.760
Why?
Droughts
4
2023
8
0.760
Why?
Follow-Up Studies
11
2024
2190
0.760
Why?
Candida
4
2020
60
0.740
Why?
Choroiditis
1
2020
9
0.740
Why?
Child
16
2024
6851
0.740
Why?
Treatment Outcome
15
2024
5155
0.730
Why?
Retinal Vein
2
2019
2
0.700
Why?
Eye Diseases
3
2024
38
0.690
Why?
Photography
4
2013
32
0.690
Why?
Eyeglasses
1
2019
9
0.690
Why?
Crohn Disease
1
2020
90
0.690
Why?
Surgical Instruments
1
2019
28
0.680
Why?
Trichoderma
1
2019
1
0.680
Why?
Plant Diseases
1
2019
8
0.680
Why?
Pseudophakia
5
2023
11
0.680
Why?
Suture Techniques
2
2022
59
0.660
Why?
Fovea Centralis
1
2018
5
0.640
Why?
Laser Therapy
1
2019
84
0.640
Why?
Basement Membrane
1
2018
18
0.640
Why?
Imaging, Three-Dimensional
1
2019
153
0.630
Why?
HIV Infections
1
2022
357
0.630
Why?
National Health Programs
2
2015
18
0.620
Why?
Vascular Endothelial Growth Factor A
5
2022
202
0.620
Why?
Incidence
11
2024
1006
0.600
Why?
Fluocinolone Acetonide
1
2017
5
0.600
Why?
Egypt
4
2022
13
0.600
Why?
Air
2
2016
23
0.580
Why?
Prospective Studies
8
2024
2379
0.570
Why?
Minerals
1
2016
30
0.550
Why?
Sodium Chloride
1
2016
58
0.540
Why?
Chorioretinitis
3
2024
9
0.540
Why?
Vitreous Detachment
1
2016
1
0.540
Why?
Acetates
1
2016
49
0.540
Why?
Dissection
1
2016
14
0.530
Why?
Ophthalmologic Surgical Procedures
1
2016
21
0.520
Why?
Registries
2
2018
522
0.520
Why?
Anesthesia, Local
1
2015
15
0.510
Why?
Adrenergic alpha-1 Receptor Antagonists
2
2020
8
0.500
Why?
Child, Preschool
10
2024
3883
0.490
Why?
Cross-Sectional Studies
6
2024
1554
0.480
Why?
Microvessels
2
2024
31
0.470
Why?
Device Removal
1
2014
85
0.440
Why?
Treponema pallidum
3
2024
10
0.440
Why?
Iris
3
2022
5
0.430
Why?
Patient Education as Topic
3
2024
313
0.420
Why?
Vitreous Body
5
2020
19
0.400
Why?
Physical Examination
2
2013
90
0.400
Why?
Scleral Buckling
3
2023
4
0.390
Why?
Optic Disk
2
2021
21
0.390
Why?
Mydriatics
1
2011
12
0.390
Why?
Microscopy
1
2011
57
0.380
Why?
Seasons
2
2022
82
0.360
Why?
Vision Disorders
4
2022
57
0.360
Why?
Diagnostic Techniques, Ophthalmological
2
2023
11
0.350
Why?
Genotype
2
2023
534
0.340
Why?
Anti-Bacterial Agents
5
2024
747
0.340
Why?
Fibrinolytic Agents
2
2023
125
0.340
Why?
Intraoperative Period
2
2019
45
0.340
Why?
Vision, Low
2
2022
9
0.340
Why?
Fundus Oculi
3
2024
25
0.330
Why?
Lens Capsule, Crystalline
2
2016
2
0.330
Why?
Tonometry, Ocular
2
2024
5
0.320
Why?
Adrenergic alpha-Antagonists
1
2008
27
0.320
Why?
United States
7
2024
4874
0.310
Why?
Silicone Oils
3
2023
3
0.310
Why?
Eye Infections, Viral
1
2008
2
0.310
Why?
Ocular Hypotension
1
2008
2
0.310
Why?
Eye Infections, Parasitic
1
2008
2
0.310
Why?
Choroid Neoplasms
1
2007
6
0.300
Why?
Suction
1
2008
24
0.300
Why?
Phenotype
2
2022
733
0.300
Why?
Physicians, Family
1
2008
64
0.300
Why?
Eye Burns
1
2007
1
0.290
Why?
Ophthalmic Solutions
1
2007
19
0.290
Why?
Sulfonamides
1
2008
128
0.290
Why?
Hyaluronic Acid
1
2007
34
0.290
Why?
Anti-Infective Agents
1
2008
95
0.280
Why?
Adolescent
9
2024
6390
0.280
Why?
Vaccination
3
2024
271
0.270
Why?
Young Adult
8
2024
3981
0.260
Why?
Trabeculectomy
1
2024
10
0.240
Why?
Glaucoma Drainage Implants
1
2024
6
0.240
Why?
Cohort Studies
2
2022
1422
0.240
Why?
Vitreoretinopathy, Proliferative
1
2024
2
0.240
Why?
Syphilis Serodiagnosis
1
2024
4
0.240
Why?
Risk Factors
8
2024
3629
0.230
Why?
Garlic
1
2024
5
0.230
Why?
Proanthocyanidins
1
2024
4
0.230
Why?
Ciliary Arteries
1
2024
3
0.230
Why?
Abducens Nerve Diseases
1
2024
8
0.230
Why?
Burns, Chemical
1
2024
9
0.230
Why?
Melanoma
1
2007
290
0.230
Why?
Search Engine
1
2023
7
0.230
Why?
Health Knowledge, Attitudes, Practice
1
2008
486
0.230
Why?
Consumer Health Information
1
2023
16
0.230
Why?
Glaucoma, Open-Angle
1
2024
21
0.230
Why?
Inflammation
3
2022
604
0.230
Why?
Tattooing
1
2023
5
0.220
Why?
Sex Workers
1
2023
2
0.220
Why?
Geographic Atrophy
1
2023
7
0.220
Why?
Drainage
1
2023
79
0.220
Why?
Fibrinolysin
1
2023
2
0.220
Why?
Cultural Diversity
1
2023
39
0.220
Why?
Schools, Medical
1
2023
70
0.220
Why?
Retreatment
2
2014
56
0.220
Why?
ROC Curve
1
2023
232
0.220
Why?
Patient Selection
1
2024
253
0.220
Why?
Faculty, Medical
1
2023
92
0.210
Why?
Subretinal Fluid
1
2022
2
0.210
Why?
Vision Screening
1
2022
12
0.210
Why?
Blood-Retinal Barrier
1
2022
6
0.210
Why?
Sudan
1
2022
2
0.210
Why?
Disease Management
2
2021
176
0.210
Why?
Privacy
1
2022
17
0.210
Why?
Antibodies, Monoclonal, Humanized
2
2015
225
0.200
Why?
Cyanoacrylates
1
2021
6
0.200
Why?
Fibrin Tissue Adhesive
1
2021
12
0.200
Why?
Recombinant Fusion Proteins
1
2022
186
0.200
Why?
Prednisone
1
2022
101
0.200
Why?
Eye Abnormalities
1
2021
25
0.200
Why?
Vision, Ocular
1
2021
11
0.200
Why?
Infant
5
2024
3563
0.200
Why?
Eye
1
2021
32
0.200
Why?
Ecosystem
1
2022
64
0.190
Why?
Sensitivity and Specificity
1
2023
863
0.190
Why?
Prevalence
3
2022
951
0.190
Why?
Tomography, X-Ray Computed
2
2022
1161
0.190
Why?
Genome-Wide Association Study
1
2022
166
0.190
Why?
Diabetes Mellitus, Type 1
1
2024
201
0.190
Why?
Disease Outbreaks
1
2022
125
0.190
Why?
Randomized Controlled Trials as Topic
1
2024
550
0.190
Why?
Prolapse
1
2020
6
0.190
Why?
Fungemia
1
2021
37
0.190
Why?
Electronic Health Records
3
2018
213
0.190
Why?
Swine
1
2021
396
0.180
Why?
Oximetry
2
2011
67
0.180
Why?
Ophthalmoscopy
1
2020
14
0.180
Why?
Macula Lutea
1
2020
3
0.180
Why?
Carcinoma, Hepatocellular
1
2022
193
0.180
Why?
Bacteria
1
2022
222
0.180
Why?
Retinal Pigment Epithelium
1
2020
18
0.180
Why?
Blindness
2
2022
31
0.180
Why?
Algorithms
1
2023
618
0.180
Why?
Substance Abuse, Intravenous
1
2020
43
0.170
Why?
Polymorphism, Single Nucleotide
1
2022
485
0.170
Why?
Fusariosis
1
2019
6
0.170
Why?
Plant Roots
1
2019
33
0.170
Why?
Fusarium
1
2019
31
0.170
Why?
Referral and Consultation
3
2013
285
0.170
Why?
Quantitative Trait Loci
1
2019
42
0.160
Why?
Hepatitis C
1
2020
79
0.160
Why?
Liver Neoplasms
1
2022
328
0.160
Why?
MicroRNAs
1
2022
355
0.160
Why?
Water
1
2019
75
0.160
Why?
Emergencies
2
2009
86
0.160
Why?
Antibiotic Prophylaxis
1
2019
61
0.160
Why?
Chromosome Mapping
1
2019
156
0.160
Why?
Animals
3
2024
13246
0.160
Why?
Equipment Design
1
2019
285
0.160
Why?
Alleles
1
2019
251
0.160
Why?
Gaucher Disease
1
2018
16
0.160
Why?
Health Literacy
3
2024
128
0.150
Why?
Surgical Wound Infection
1
2019
116
0.150
Why?
Recurrence
2
2011
662
0.150
Why?
Sulfur Hexafluoride
1
2017
2
0.150
Why?
Treatment Failure
1
2018
116
0.150
Why?
Drug Therapy, Combination
2
2016
381
0.150
Why?
Diabetes Mellitus, Type 2
1
2024
486
0.150
Why?
Eye Diseases, Hereditary
1
2017
5
0.150
Why?
Inheritance Patterns
1
2017
22
0.150
Why?
Fatty Acids
1
2018
145
0.140
Why?
Penicillins
1
2017
28
0.140
Why?
Contrast Media
1
2018
185
0.140
Why?
Time Factors
3
2020
2922
0.140
Why?
Microsurgery
2
2024
30
0.130
Why?
Drug Combinations
1
2016
126
0.130
Why?
Video Recording
1
2016
80
0.130
Why?
Anesthetics, General
1
2015
4
0.130
Why?
Visually Impaired Persons
1
2015
1
0.130
Why?
Dose-Response Relationship, Drug
2
2016
1378
0.120
Why?
England
2
2012
45
0.120
Why?
Anesthetics, Local
1
2015
75
0.120
Why?
Acute Disease
2
2021
368
0.120
Why?
Microscopy, Acoustic
1
2013
5
0.120
Why?
Language
2
2024
134
0.110
Why?
Diagnosis, Differential
3
2017
1043
0.110
Why?
Glaucoma, Neovascular
1
2012
2
0.110
Why?
Infusions, Intravenous
2
2017
213
0.110
Why?
Syndrome
2
2011
238
0.100
Why?
Risk Assessment
1
2016
1262
0.100
Why?
Mutation
1
2017
1294
0.100
Why?
Muscle Hypotonia
1
2011
21
0.090
Why?
Risperidone
1
2011
25
0.090
Why?
Eye Hemorrhage
1
2010
1
0.090
Why?
Cranial Sinuses
1
2010
10
0.090
Why?
Carotid Artery Injuries
1
2010
13
0.090
Why?
Arteriovenous Fistula
1
2010
22
0.090
Why?
Prostaglandins F, Synthetic
1
2009
1
0.080
Why?
Anti-Inflammatory Agents
1
2011
160
0.080
Why?
Prednisolone
1
2009
55
0.080
Why?
Carbonic Anhydrase Inhibitors
1
2008
5
0.080
Why?
Antipsychotic Agents
1
2011
232
0.080
Why?
Acetazolamide
1
2008
18
0.080
Why?
Oxygen
1
2011
325
0.080
Why?
Pupil
1
2008
30
0.080
Why?
Vitreous Hemorrhage
1
2008
5
0.080
Why?
Prostatic Hyperplasia
1
2008
39
0.080
Why?
Mass Screening
1
2011
346
0.080
Why?
Injections
1
2008
56
0.080
Why?
Electroretinography
2
2018
15
0.080
Why?
Cefuroxime
1
2007
3
0.080
Why?
Models, Biological
1
2011
723
0.080
Why?
Cefazolin
1
2007
12
0.070
Why?
Capsulorhexis
1
2007
1
0.070
Why?
Rupture
1
2007
24
0.070
Why?
Astigmatism
1
2007
5
0.070
Why?
Neoplasm Metastasis
1
2007
236
0.070
Why?
Chronic Disease
1
2009
571
0.070
Why?
Clinical Competence
1
2008
392
0.060
Why?
Reagins
1
2024
2
0.060
Why?
Posterior Eye Segment
1
2024
2
0.060
Why?
Sex Distribution
1
2024
133
0.060
Why?
Prosthesis Implantation
1
2024
46
0.060
Why?
Antibodies, Bacterial
1
2024
28
0.060
Why?
Rumen
1
2024
1
0.060
Why?
Tannins
1
2024
3
0.060
Why?
Fermentation
1
2024
8
0.060
Why?
Goats
1
2024
11
0.060
Why?
Diplopia
1
2024
20
0.060
Why?
Teaching Materials
1
2024
31
0.060
Why?
Animal Feed
1
2024
56
0.060
Why?
Reading
1
2024
83
0.060
Why?
Antifungal Agents
1
2006
339
0.060
Why?
Immunoglobulin G
1
2024
186
0.060
Why?
Anesthesia
1
2024
73
0.060
Why?
Homosexuality, Male
1
2023
51
0.050
Why?
Surgical Flaps
1
2024
120
0.050
Why?
Retinal Ganglion Cells
1
2022
13
0.050
Why?
Traction
1
2021
7
0.050
Why?
Reoperation
2
2014
454
0.050
Why?
Socioeconomic Factors
1
2023
579
0.050
Why?
Health Status Disparities
1
2023
194
0.050
Why?
Atrophy
1
2020
38
0.040
Why?
Diet
1
2024
557
0.040
Why?
Emergency Service, Hospital
1
2024
484
0.040
Why?
Healthcare Disparities
1
2023
268
0.040
Why?
Europe
1
2019
76
0.040
Why?
Pandemics
1
2024
562
0.040
Why?
Gene Expression Regulation, Neoplastic
1
2022
828
0.040
Why?
Administration, Oral
2
2011
434
0.040
Why?
Glucosylceramidase
1
2018
9
0.040
Why?
Enzyme Replacement Therapy
1
2018
17
0.040
Why?
Visual Fields
1
2018
37
0.040
Why?
Transplantation, Autologous
1
2020
469
0.040
Why?
Prone Position
1
2017
31
0.040
Why?
Genes, Recessive
1
2017
16
0.040
Why?
Consanguinity
1
2017
18
0.040
Why?
Heterozygote
1
2017
81
0.040
Why?
Pedigree
1
2017
125
0.040
Why?
DNA Mutational Analysis
1
2017
176
0.030
Why?
Recombinant Proteins
1
2018
487
0.030
Why?
Genetic Association Studies
1
2017
116
0.030
Why?
Genetic Testing
1
2017
119
0.030
Why?
Rupture, Spontaneous
1
2016
20
0.030
Why?
Practice Guidelines as Topic
1
2019
449
0.030
Why?
Pregnancy
1
2023
2604
0.030
Why?
Survival Analysis
1
2016
666
0.030
Why?
Gonioscopy
1
2012
3
0.030
Why?
Age Distribution
1
2013
168
0.030
Why?
Choroidal Neovascularization
1
2013
54
0.030
Why?
Neovascularization, Pathologic
1
2012
162
0.020
Why?
Retinal Artery
1
2011
4
0.020
Why?
Coloring Agents
1
2011
70
0.020
Why?
Serotonin 5-HT2 Receptor Antagonists
1
2011
9
0.020
Why?
Indocyanine Green
1
2011
34
0.020
Why?
Dopamine Antagonists
1
2011
21
0.020
Why?
Angiography
1
2011
130
0.020
Why?
Injections, Intraocular
1
2010
6
0.020
Why?
Regional Blood Flow
1
2011
108
0.020
Why?
Methylprednisolone
1
2010
38
0.020
Why?
Orbit
1
2010
29
0.020
Why?
Chemotherapy, Adjuvant
1
2011
120
0.020
Why?
Adrenal Cortex Hormones
1
2011
94
0.020
Why?
Schizophrenia
1
2011
256
0.020
Why?
Immunosuppressive Agents
1
2011
222
0.020
Why?
Sweden
1
2007
9
0.020
Why?
Sallam's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description